Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New SEC rule - don't worry our BOD screwed up enough to buy 3 more yrs!

A conundrum.

If the Rule is made effective as of November 1, 2010, when was PTSC's most recently completed second fiscal quarter?

The closing price on November 30, 2009 was 18 cents.

If, as you suggest, this was "a clever ploy by our BoD to stay small", wouldn't "genius ploy" be more correct for having had such amazing foresight?

.

.

.

Be well

Share
New Message
Please login to post a reply